Jim Simons's position in Outlook Therapeutics is currently worth $896 Thousand. That's 0.00% of their equity portfolio (2324th largest holding). The first Outlook Therapeutics trade was made in Q1 2019. Since then Jim Simons bought shares six more times and sold shares on eight occasions. The stake costed the investor $44.6 Thousand, netting the investor a gain of 1911% so far.